Literature DB >> 7688748

The use of serum tumor markers in the management of patients with malignancy.

M Markman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7688748     DOI： 10.1007/bf01215980

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  3 in total

1.  CA 125 serum levels correlated with second-look operations among ovarian cancer patients.

Authors:  J S Berek; R C Knapp; G D Malkasian; P T Lavin; C Whitney; J M Niloff; R C Bast
Journal:  Obstet Gynecol       Date:  1986-05       Impact factor: 7.661

2.  Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.

Authors:  P H Lange; K R McIntire; T A Waldmann; T R Hakala; E E Fraley
Journal:  N Engl J Med       Date:  1976-11-25       Impact factor: 91.245

3.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.